Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Female condoms

W Bounds1

  • 1Margaret Pyke Family Planning Centre, London, UK.

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

The female condom, Femidom, shows contraceptive efficacy similar to male condoms, but correct use is crucial for effectiveness. Further research is needed on its role in preventing sexually transmitted infections and long-term user acceptability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of children's body mass index: a longitudinal study of diet and growth in children aged 2-8 y.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same author

Pilot study of short-term acceptability and breakage and slippage rates for the loose-fitting polyurethane male condom eZ.on bi-directional: a randomized cross-over trial.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2002
Same author

Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.

British journal of haematology·2001
Same author

'CE-Marking' on contraceptive devices: what does it mean?

The British journal of family planning·2000
Same author

Longitudinal study of nutrient and food intakes of white preschool children aged 24 to 60 months.

Journal of the American Dietetic Association·1999
Same author

Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.

The British journal of family planning·1999

Area of Science:

  • Reproductive Health
  • Contraception
  • Sexual Health

Background:

  • Early female condom designs from the 1920s and 1960s saw limited use.
  • The urgent need for female-controlled barrier methods, driven by the AIDS epidemic, revived scientific interest in the 1980s.
  • Development of new female condom designs, including Femidom (Reality), emerged in the 1980s.

Purpose of the Study:

  • To evaluate the development, clinical testing, and potential of the polyurethane female condom, Femidom.
  • To assess the contraceptive efficacy and potential for sexually transmitted disease prevention offered by Femidom.
  • To explore the user acceptability and long-term role of Femidom in sexual health.

Main Methods:

  • Review of laboratory studies and clinical trials on Femidom's efficacy.

Related Experiment Videos

  • Analysis of reported 'typical-use' and 'perfect-use' pregnancy rates.
  • Examination of evidence regarding protection against sexually transmitted infections.

    • Main Results:

    • Femidom's contraceptive efficacy appears similar to male condoms, with 'perfect-use' rates indicating high effectiveness.
    • 'Typical-use' pregnancy rates vary, highlighting the importance of correct and consistent usage.
    • Evidence for protection against sexually transmitted infections is limited, primarily based on laboratory findings.

    Conclusions:

    • Femidom represents a significant advancement in female-controlled barrier contraceptives.
    • Its effectiveness in preventing pregnancy and STIs relies heavily on correct and consistent user application.
    • Further clinical studies are essential to determine Femidom's long-term value and user acceptability in sexual health and contraception.